Search research articles
Contact Us
Filters
Showing results (11-20 of 74) with videos related to
Page
of 8
Sort By:
Current Rheumatology Reviews
|
August 3, 2010
Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design
Dinesh Khanna, James R Seibold, Athol Wells, et al.
The Journal of Rheumatology
|
September 17, 2010
Discordance between patient and physician assessments of disease severity in systemic sclerosis
Marie Hudson, Ann Impens, Murray Baron, et al.
The Journal of Rheumatology
|
January 6, 2006
Bosentan in pulmonary arterial hypertension secondary to scleroderma
Amit Joglekar, Fausan S Tsai, Deborah A McCloskey, et al.
Arthritis Care & Research
|
April 3, 2014
Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis
Alexandra B Wiese, Veronica J Berrocal, Daniel E Furst, et al.
Rheumatology (Oxford, England)
|
February 11, 2015
Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis
Beth Wallace, Suzanne Kafaja, Daniel E Furst, et al.
Rheumatology (Oxford, England)
|
May 29, 2025
An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP
Ariane L Herrick, Andrea Murray, Graham Dinsdale, et al.
The Journal of Rheumatology
|
January 19, 2008
Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization
Vivien M Hsu, Abel E Moreyra, Alan C Wilson, et al.
Rheumatology (Oxford, England)
|
July 17, 2009
Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials
Marian Kaldas, Puja P Khanna, Daniel E Furst, et al.
The Journal of Rheumatology
|
September 17, 2009
Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis
Elena Schiopu, Vivien M Hsu, Ann J Impens, et al.
The Journal of Rheumatology
|
July 5, 2011
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Dinesh Khanna, Daniel E Furst, Paul Maranian, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 74) with videos related to
Sort By:
Page
of 8
Current Rheumatology Reviews
|
August 3, 2010
Systemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design
Dinesh Khanna, James R Seibold, Athol Wells, et al.
The Journal of Rheumatology
|
September 17, 2010
Discordance between patient and physician assessments of disease severity in systemic sclerosis
Marie Hudson, Ann Impens, Murray Baron, et al.
The Journal of Rheumatology
|
January 6, 2006
Bosentan in pulmonary arterial hypertension secondary to scleroderma
Amit Joglekar, Fausan S Tsai, Deborah A McCloskey, et al.
Arthritis Care & Research
|
April 3, 2014
Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosis
Alexandra B Wiese, Veronica J Berrocal, Daniel E Furst, et al.
Rheumatology (Oxford, England)
|
February 11, 2015
Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis
Beth Wallace, Suzanne Kafaja, Daniel E Furst, et al.
Rheumatology (Oxford, England)
|
May 29, 2025
An exploratory trial of a single dose of CAM2043 (treprostinil subcutaneous depot) in SSc-related RP
Ariane L Herrick, Andrea Murray, Graham Dinsdale, et al.
The Journal of Rheumatology
|
January 19, 2008
Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization
Vivien M Hsu, Abel E Moreyra, Alan C Wilson, et al.
Rheumatology (Oxford, England)
|
July 17, 2009
Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials
Marian Kaldas, Puja P Khanna, Daniel E Furst, et al.
The Journal of Rheumatology
|
September 17, 2009
Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis
Elena Schiopu, Vivien M Hsu, Ann J Impens, et al.
The Journal of Rheumatology
|
July 5, 2011
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
Dinesh Khanna, Daniel E Furst, Paul Maranian, et al.
Page
of 8